Invesaro

Stocks Comparison

Datz World vs Pharma-Bio Serv: revenue, profit, margins and growth compared

Datz World brought in $6.5M of revenue in fiscal 2025, Pharma-Bio Serv $9M in fiscal 2025. Revenue changed by +15.5% at Datz World and -5.3% at Pharma-Bio Serv on the year before, so Datz World grew faster. Datz World kept 4.0% of its revenue as net profit, Pharma-Bio Serv -1.1%.

Side by side, latest fiscal year

BOTXPBSV
Fiscal year endedFY2025 (June 30, 2025)FY2025 (October 31, 2025)
Revenue$6.5M$9M
Revenue growth+15.5%-5.3%
Net income$260.7K-$100.5K
Net margin4.0%-1.1%
Free cash flown/a-$221.5K
Free cash flow marginn/a-2.5%
Earnings per share (diluted)$0.00-$0.00
Cash$853.8K$3.4M
Debtn/an/a
Price to earningsn/an/a
Market value$5.4M$8M
Dividend yieldn/an/a
Rank by revenue in sector#513 of 587 · Industrials#508 of 587 · Industrials

Over the years

Revenue
BOTX FY2018: $1.1MBOTX FY2019: $1.8MBOTX FY2020: $2.5MBOTX FY2021: $2.7MBOTX FY2022: $3.8MBOTX FY2023: $5.1MBOTX FY2024: $5.6MBOTX FY2025: $6.5MPBSV FY2018: $17.8MPBSV FY2019: $19.5MPBSV FY2020: $21.6MPBSV FY2021: $20.1MPBSV FY2022: $19.4MPBSV FY2023: $17MPBSV FY2024: $9.5MPBSV FY2025: $9MFY18FY19FY20FY21FY22FY23FY24FY25
BOTX $6.5MPBSV $9M
Net income
BOTX FY2018: -$3MBOTX FY2019: -$6.6MBOTX FY2020: $1.3MBOTX FY2021: -$5MBOTX FY2022: $955.7KBOTX FY2023: -$585.2KBOTX FY2024: -$709.4KBOTX FY2025: $260.7KPBSV FY2018: $1.3MPBSV FY2019: $2.1MPBSV FY2020: $2.1MPBSV FY2021: -$2.1MPBSV FY2022: $1MPBSV FY2023: $1.3MPBSV FY2024: -$777.6KPBSV FY2025: -$100.5KFY18FY19FY20FY21FY22FY23FY24FY25
BOTX $260.7KPBSV -$100.5K
Net margin
BOTX FY2018: -264.1%BOTX FY2019: -366.2%BOTX FY2020: 51.5%BOTX FY2021: -188.6%BOTX FY2022: 25.1%BOTX FY2023: -11.5%BOTX FY2024: -12.7%BOTX FY2025: 4.0%PBSV FY2018: 7.2%PBSV FY2019: 10.7%PBSV FY2020: 9.5%PBSV FY2021: -10.4%PBSV FY2022: 5.2%PBSV FY2023: 7.7%PBSV FY2024: -8.2%PBSV FY2025: -1.1%FY18FY19FY20FY21FY22FY23FY24FY25
BOTX 4.0%PBSV -1.1%
Revenue growth
BOTX FY2019: +58.6%BOTX FY2020: +41.3%BOTX FY2021: +5.5%BOTX FY2022: +42.8%BOTX FY2023: +33.7%BOTX FY2024: +10.0%BOTX FY2025: +15.5%PBSV FY2019: +9.6%PBSV FY2020: +10.5%PBSV FY2021: -6.7%PBSV FY2022: -3.6%PBSV FY2023: -12.5%PBSV FY2024: -44.0%PBSV FY2025: -5.3%FY19FY20FY21FY22FY23FY24FY25
BOTX +15.5%PBSV -5.3%
Free cash flow
PBSV FY2018: $3.6MPBSV FY2019: -$2.3MPBSV FY2020: $1.5MPBSV FY2021: $794KPBSV FY2022: $573.2KPBSV FY2023: $1.9MPBSV FY2024: -$726.4KPBSV FY2025: -$221.5KFY18FY19FY20FY21FY22FY23FY24FY25
BOTXPBSV -$221.5K

Fiscal years as each company reports them; the two may end in different months.

Questions about Datz World and Pharma-Bio Serv

Which is bigger by revenue, Datz World or Pharma-Bio Serv?

Pharma-Bio Serv is bigger by revenue: $9M in fiscal 2025, against $6.5M for Datz World in fiscal 2025.

Which keeps more of its revenue as profit, Datz World or Pharma-Bio Serv?

Datz World had a net margin of 4.0% in fiscal 2025; Pharma-Bio Serv had -1.1% in fiscal 2025.

Which grew revenue faster, Datz World or Pharma-Bio Serv?

In their latest fiscal years revenue changed by +15.5% at Datz World and -5.3% at Pharma-Bio Serv.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies